LANDOVER, Md., Sept. 20, 2017 -- The Asthma and Allergy Foundation of America (AAFA) and Allergy Standards Limited (ASL) announced today that certain products in the AllerCot bedding line from Indo Count have earned asthma & allergy friendly® Certification.
The asthma & allergy friendly® Certification Program, an independent program administered in the United States by AAFA, with their partner ASL, helps consumers identify products more suitable for people with asthma and allergies.
“We are thrilled to have our products be accepted into the asthma & allergy friendly® Certification Program,” said KK Lalpuria, Executive Director of Indo Count. “The rigorous testing is assurance that these products are a safer and healthier choice for people affected by asthma and allergies. Joining the Certification Program is one way we fulfill our Corporate Social Responsibility goals of helping to improve people’s quality of life.”
Allergen avoidance in the home is now accepted as part of a preventative treatment plan for those with asthma and allergies. It is a complement to the overall concept of home health. An individual’s exposure to allergens is considerably reduced when bedding products are washed regularly to remove allergens that accumulate over time.
The asthma & allergy friendly® Certification Mark is awarded only to products that meet the Certification Program’s strict scientific standards. To earn the mark, bedding must:
- Be an effective barrier to the passage of allergens
- Be breathable for comfort
- Be easily cleaned to remove allergens
- Withstand the wear and tear of the recommended cleaning methods
- Have no chemicals or irritants known to trigger asthma and allergy symptoms
Certain products in the AllerCot bedding line from Indo Count meet these standards and are now Certified asthma & allergy friendly®.
“The Asthma and Allergy Foundation of America is honored to have some of Indo Count’s products earn the asthma & allergy friendly® Certification Mark,” said AAFA’s Acting CEO Lynda Mitchell. “The Certification Program is one way we fulfill our mission to improve the lives of people with asthma and allergic diseases.”
“After rigorous scientific testing, we are pleased to announce that Indo Count’s bedding products have met the requirements for certification,” said Dr. John McKeon, CEO of ASL. “The sheets and pillowcases tested performed well under our standards and will be a great addition to the asthma & allergy friendly® Certification Program.”
About the asthma & allergy friendly® Certification Program
The asthma & allergy friendly® Certification Program is a unique, groundbreaking collaboration between the Asthma and Allergy Foundation of America and Allergy Standards Limited. The program tests and certifies products to prove their suitability for people with asthma and allergies. The program works with retailers and manufacturers to offer consumers products for a #healthierhome. Certified products include air cleaners, dehumidifiers, paints, bedding, vacuum cleaners, washing machines, stuffed toys, cleaning services and more. Visit aafa.org/certified for more information.
About Indo Count
Indo Count is an India-based home textile company that is one of the leading players in the global Home Textile industry. It engages in the activity of manufacture of textile products including bedding, quilts, pillows, sleeping bags and others, and preparation and spinning of cotton fibers, including blended cotton. Indo Count exports its products to approximately 50 countries in over five continents.
Attachments:
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/f80260da-e4a6-4af4-b873-5e73f5d2020f
Attachments:
http://www.globenewswire.com/NewsRoom/AttachmentNg/c2935982-005e-49db-b36b-ede1ac9e58b9
Attachments:
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/554c621d-9668-4a7b-8775-5248113d8426
Michele Cassalia asthma & allergy friendly Certification Program 202-466-7643 ext. 259 [email protected]


Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market
ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio
FDA Approves Mitapivat for Anemia in Thalassemia Patients
Texas App Store Age Verification Law Blocked by Federal Judge in First Amendment Ruling
DOJ Reaches Settlement With Blackstone’s LivCor Over Alleged Rent Price-Fixing
Hyundai Recalls Over 51,000 Vehicles in the U.S. Due to Fire Risk From Trailer Wiring Issue
BP Nears $10 Billion Castrol Stake Sale to Stonepeak
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Nvidia to Acquire Groq in $20 Billion Deal to Boost AI Chip Dominance
California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage
Waymo Plans Safety and Emergency Response Upgrades After San Francisco Robotaxi Disruptions
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift 



